SEC Form 4 · accession 0001127602-15-024050
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph L Herring
Officer — CEO of Covance Drug Division
Period of report
Jul 31, 2015
Accepted (ET)
Aug 4, 2015 · 2:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2015 | M | 19,990 | — | A | 19,990 | D | |
| Common Stock | Jul 31, 2015 | F | 9,586 | $127.29 | D | 10,404 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F3 | — | Jul 31, 2015 | M | 19,990 | D | Jul 31, 2015 | — | Common Stock | 19,990 | 0 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Stock withholding to satisfy tax withholding obligations.
- F3On February 23, 2015, the reporting person was granted 19,990 Restricted Stock Units, which vested in full on July 31, 2015.